Trial Profile

Protocol to investigate the effect of cyclo-oxyganase (COX)-2 inhibition on reducing central sensitisation of pain in osteoarthritis.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 29 Nov 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Etoricoxib (Primary)
Indications Musculoskeletal pain; Osteoarthritis
Focus Therapeutic Use

Most Recent Events

12 Jul 2011 Status changed from completed to recruiting as reported by European Clinical Trials Database record.
12 Jul 2011 New source identified and integrated (European Clinical Trials Database record).
01 Mar 2009 Status changed from recruiting to completed as reported by ISRCTN.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com